Pharma leader, Lupin, recorded a strong jump in net profit at 74% along with margin expansion of 23%. The company's US sales rose to ₹1,834 crore from ₹1,776 crore in the previous year. Ramesh Swaminathan, Executive Director & Global CFO of Lupin joins in to share his take on the company's Q2 numbers and how their new product pipeline with aid their growth.
#lupinsharenews #lupinshare #lupinpharma
--------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: [ Ссылка ]
Visit NDTV Profit for more news: [ Ссылка ]
Don't enter the stock market unaware. Read all Research Reports here: [ Ссылка ]
Follow NDTV Profit here
Twitter: [ Ссылка ] , [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
